(0.28%) 5 195.20 points
(0.16%) 38 915 points
(0.16%) 16 376 points
(0.38%) $78.78
(0.46%) $2.21
(-0.30%) $2 324.10
(-0.15%) $27.57
(2.65%) $990.50
(0.11%) $0.929
(0.71%) $10.90
(0.35%) $0.799
(-0.08%) $91.27
-11.89% $ 0.620
Live Chart Being Loaded With Signals
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders...
Stats | |
---|---|
Volumen de hoy | 346 280 |
Volumen promedio | 57 185.00 |
Capitalización de mercado | 4.26M |
EPS | $0 ( 2024-03-21 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.340 |
ATR14 | $0.00300 (0.48%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-19 | Ault Milton C Iii | Buy | 1 000 | Common Stock |
2024-04-01 | Ault Milton C Iii | Buy | 334 | Common Stock |
2024-01-05 | Ault Milton C Iii | Buy | 2 000 | Common Stock |
2024-03-26 | Ault Milton C Iii | Buy | 780 000 | Warrants |
2024-03-26 | Ault Milton C Iii | Buy | 780 | Series B Convertible Preferred Stock |
INSIDER POWER |
---|
-10.07 |
Last 96 transactions |
Buy: 11 786 230 | Sell: 5 921 131 |
Volumen Correlación
Alzamend Neuro, Inc. Correlación
10 Correlaciones Más Positivas | |
---|---|
SEDG | 0.983 |
IMUX | 0.974 |
CFRX | 0.973 |
RIDE | 0.973 |
BXRX | 0.971 |
ELEV | 0.97 |
BNGO | 0.969 |
IRDM | 0.968 |
FNCH | 0.967 |
RELI | 0.967 |
10 Correlaciones Más Negativas | |
---|---|
ADAL | -0.973 |
SLMBP | -0.973 |
HCNE | -0.971 |
VMGA | -0.97 |
JUGG | -0.967 |
IXAQ | -0.966 |
HORI | -0.966 |
GPAC | -0.966 |
LCAA | -0.964 |
IBEX | -0.962 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Alzamend Neuro, Inc. Correlación - Moneda/Commodity
Alzamend Neuro, Inc. Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-23 066.00 (0.00 %) |
EPS: | $-2.29 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-23 066.00 (0.00 %) |
EPS: | $-2.29 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-2.09 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.0594 |
Financial Reports:
No articles found.
Alzamend Neuro, Inc.
Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and AL002 that completed preclinical stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico